Showing results (31-40 of 119) with videos related to
Sort By:
Pageof 12
Inflammatory Bowel Diseases|February 7, 2013
Phylogenetic analysis of dysbiosis in ulcerative colitis during remissionMirjana Rajilić-Stojanović, Fergus Shanahan, Francisco Guarner, et al.Gastroenterologia Y Hepatologia|September 28, 2024
Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBDVirginia Robles-Alonso, Roser Solans, Ernesto Lastiri, et al.The British Journal of Nutrition|July 19, 2005
Should yoghurt cultures be considered probiotic?Francisco Guarner, Gabriela Perdigon, Gérard Corthier, et al.International Journal of Molecular Sciences|February 15, 2022
Anti-Inflammatory Effect of an O-2-Substituted (1-3)-β-D-Glucan Produced by Pediococcus parvulus 2.6 in a Caco-2 PMA-THP-1 Co-Culture ModelSara Notararigo, Encarnación Varela, Anna Otal, et al.Journal of Clinical Gastroenterology|July 12, 2014
Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency QuestionnaireFernando Azpiroz, Denis Guyonnet, Yves Donazzolo, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 21, 2015
Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its functionPaula Fernández-Calotti, Olga Casulleras, María Antolin, et al.Advances in Therapy|January 29, 2024
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?Dan Waitzberg, Francisco Guarner, Iva Hojsak, et al.Journal of Crohn'S & Colitis|March 9, 2012
Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatmentFrancesc Casellas, Virginia Robles, Natalia Borruel, et al.Revista Espanola De Enfermedades Digestivas|March 17, 2022
Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreakClaudia Herrera-de Guise, Luis Fernando Mayorga Ayala, Xavier Serra Ruiz, et al.Frontiers in Cellular and Infection Microbiology|December 17, 2020
Antibiotics as Major Disruptors of Gut MicrobiotaJaime Ramirez, Francisco Guarner, Luis Bustos Fernandez, et al.Pageof 12